The Walden Group is pleased to provide access to its Q3 2023 Strategic Healthcare M&A Report, which includes:        Q3 2023 Market Overview      Noteworthy M&A Deals By Sector      Top Deals > $100m in Transaction Value Announced or Closed in Q3 2023      Performance of Leading Healthcare Companies      Analysis of More Than 45 Q3 M&A …

The Walden Group is pleased to provide access to its Q2 2023 Strategic Healthcare M&A Report, which includes:        Q2 2023 Market Overview      Noteworthy M&A Deals By Sector      Top Deals > $100m in Transaction Value Announced or Closed in Q2 2023      Performance of Leading Healthcare Companies      Analysis of More Than 45 Q2 M&A …

The Walden Group is pleased to provide access to its Q1 2023 Strategic Healthcare M&A Report, which includes:        Q1 2023 Market Overview      Noteworthy M&A Deals By Sector      Top Deals > $100m in Transaction Value Announced or Closed in Q1 2023      Performance of Leading Healthcare Companies      Analysis of More Than 45 Q1 M&A …

Spain-based manufacturer and distributor of diagnostic instruments Werfen has acquired Immucor, a manufacturer of transfusion and transplant diagnostic devices.  The acquisition adds platelet detection, diagnostic analyzers, blood monitoring and molecular testing products that help match patients and donors.  Deal terms — $2b. Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare Mergers, Medical Devices; Diagnostics

The Walden Group is pleased to provide access to its Q4 2022 Strategic Healthcare M&A Report, which includes:       Recent Divestitures and Spin-Offs     Diagnostic and Medical Device Deals with Valuations over $100m     Noteworthy M&A Deals By Sector     Top Deals > $100m in Transaction Value Announced or Closed in 2022     Performance of …

Shockwave Medical, a $237m developer of technologies treating calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve disease, is acquiring Neovasc, a $2.5m Canada-based developer of transcatheter devices treating refractory angina and mitral valve disease.  Deal terms – $100m upfront plus $47m in milestones on sales of $2.5m (40x).     Keywords: Healthcare Investment Banking, Healthcare M&A, …

Zimmer Biomet Holdings, Inc., a $8.0b maker of orthopedic reconstructive products is acquiring Embody, Inc., a developer of collagen implants for repairing tendons, ligaments and torn rotator cuffs.  The acquisition builds Zimmer Biomet’s sports medicine offerings after it spun-off its dental and spine operations into Zimvie, a separate, publicly-traded company in March 2022.  Deal value – $155m plus $120m in …

The Walden Group is pleased to announce that it represented Total Titanium, Inc. (TTI) in its sale to a subsidiary of Bausch + Lomb Corporation (NYSE/TSX:BLCO) (“Bausch + Lomb”). TTI was one of the last remaining independently-owned manufacturers of precision ophthalmic instruments based in the United States. Bausch + Lomb is a leading global eye health company dedicated to helping people …

The Walden Group is pleased to provide access to its Q3 2022 Strategic Healthcare M&A Report, which includes:       Market Overview — What you need to know about MDR and more       Major M&A Deals by Sector       For Ophthalmology, Orthopedic & Spine, and Woundcare – Key Developments and Deals       Key …

Aspen Surgical, a producer of disposable surgical products and a portfolio company of Audax Group, has purchased Symmetry Surgical, a maker of electrosurgery products, instruments and minimally invasive surgical devices, from Roundtable Healthcare Partners.  The acquisition diversifies Aspen’s offerings into electrosurgery including bipolar forceps and generators, along with instruments for other specialties.  Terms not announced.       Keywords: Healthcare …